The Medical Minute: Stroke awareness

May 30, 2011 By Raymond K. Reichwein in Cardiology

A stroke is sudden brain injury caused by a sudden vascular (blood vessel) compromise. There are two major types of strokes. An ischemic stroke occurs when blood flow to a part of the brain is blocked by clot or other debris. This is the most common type, comprising approximately 85 percent of all strokes. The other type, hemorrhagic stroke, occurs when a blood vessel or aneurysm ruptures and blood spreads in and around the brain. Strokes can be mild, or can be quite disabling, even fatal, depending on the brain area involved and the type of stroke.

Stroke symptoms occur suddenly and without warning. The most common symptom is weakness or numbness, often on one side of the body or face. Other common symptoms include slurred or abnormal speech, confusion, visual loss or double vision, dizziness, , and severe headache. The "worst headache of my life" is commonly associated with a brain hemorrhage. The term "FAST" (Face, Arm, Speech, Time), refers to facial droop, arm weakness, slurred speech, and urgency of time. This memory tool is also a reminder to call 9-1-1 immediately if a stroke is suspected.

There are acute treatments available for both types of strokes. These treatments are time based, so earlier recognition and treatment will lead to a better outcome ("time lost is brain lost"). For , the FDA-approved clot buster intravenous t-PA must be administered within 3-4.5 hours of stroke onset. The use of IV t-PA is associated with an approximately 40 percent chance of very good outcome (near-normal or normal state) at 90 days post-stroke. There also are catheter-based procedures to remove a clot from blocked brain arteries within several hours of the stroke that have been shown to significantly improve outcomes. For brain hemorrhages, there are neurosurgical approaches and catheter-based approaches. Early treatment can significantly decrease and reduce recurrent brain bleeding and is associated with better clinical outcomes.

Many strokes -- up to 80 percent -- are preventable. Knowing the common risk factors is critical. These include high blood pressure, uncontrolled diabetes, abnormal cholesterol levels, smoking, alcohol abuse, obesity, carotid artery disease, atrial fibrillation (an irregular heart beat) and obstructive sleep apnea. For women, frequent migraine headaches (particularly with auras), birth control pill use, and advancing age (30-40s), are associated with increased stroke risk. These are all modifiable risk factors, with behavioral changes like healthy diet and exercise, or various medication therapies. For symptomatic carotid artery stenosis, one should consider a surgical intervention, called carotid endarterectomy, and, in select cases, carotid artery stenting. Anyone with at least one of these risk factors should discuss strategies for management with their primary care physician.

Another important risk factor for stroke is a transient ischemic attack, TIA, or "mini-stroke," which occurs 25 percent of the time before a stroke occurs. The symptoms are the same as a stroke, but resolve in less than an hour. Up to 20 percent of individuals who experience a TIA will later suffer a stroke. A TIA is a great window of opportunity to prevent a stroke, so prompt medical attention is needed.

Provided by Pennsylvania State University search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 20 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 23 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 23 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 23 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created May 21, 2013 | popularity 5 / 5 (1) | comments 0


Researchers find possible 'master switch' in deadly brain cancer

(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...

Depression linked to telomere enzyme, aging, chronic disease

(Medical Xpress)—The first symptoms of major depression may be behavioral, but the common mental illness is based in biology—and not limited to the brain.

Cold plasma successful against brain cancer cells

For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized ...

Vaccine blackjack: IL-21 critical to fight against viral infections

(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

Can you put a price on health?

As health services strive to improve quality and reduce costs, researchers study the benefits – and the pitfalls – of 'pay for performance' in hospitals.

Fast-acting mothers' milk for healthier babies

Human breastmilk responds quickly to protect the child when there is an infection in mothers or babies, according to new international research led by The University of Western Australia.